Terumo is Rising to the Challenges to Innovate in Three Business Areas
Terumo contributes to society through healthcare by doing business through three companies.
We provide optimal products and services to medical settings the world over. In pursuing higher quality in medicine, we introduce improvements for greater safety and ease of use, conduct training to promote proper use of devices, and propose systems for comprehensively meeting the needs of medical settings.
Net Sales by Company
- ※1 Interventional Systems: cardiac and endovascular interventional therapies
- ※2 Cardiovascular Systems: cardiac and vascular surgery
- ※3 Includes net sales of the Pharmaceutical and Nutrition Division, which was integrated in fiscal 2015.
Cardiac & Vascular Company
Through interventional therapies, which are being developed for more and more parts of the body, and technologies for cardiovascular surgery, we work to ease the physical burdens of patients
The Cardiac & Vascular Company focuses on interventions, in which diagnoses and therapies can be performed through the insertion of an interventional devices into a blood vessels, in addition to the field of cardiovascular surgeries. Interventional therapies are performed to treat diseases in various parts of the body, and Terumo makes further contributions to the treatment of coronary, peripheral, and neurovascular disease, and interventional oncology for liver cancer.
In the area of cardiovascular surgery, we develop cardiopulmonary bypass systems, artificial vascular grafts, and other products. Our goal in all of these areas is to lower physical burdens on patients and achieve better therapeutic effectiveness.
General Hospital Company
The General Hospital Company contributes to higher quality in medicine by providing medical devices and pharmaceuticals in systems designed to improve safety and ease of use
Medical treatment settings have diversified and now extend from hospitals to patients’ homes. Medical devices and pharmaceuticals, therefore, must incorporate performance and use design considerations tailored to the settings where they will be used.
The General Hospital Company offers a series of systems comprising combinations of devices and pharmaceuticals optimized by type of medical setting and patient. The company provides added value through these systems, both in the form of greater safety in medical settings and improved efficiency for medical professionals.
Blood Management Company (Terumo BCT)
The Blood Management Company drives customer value and enhances patient outcomes through blood component, therapeutic apheresis, and cellular technologies
As a global leader in blood component, therapeutic apheresis, and cellular technologies, the Blood Management Company (Terumo BCT) is the only company with the unique combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction technologies. We believe in the potential of blood to do even more for patients than it does today. This belief inspires our innovation and strengthens our collaboration with customers.